Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of Family Medicine|May 28, 2024
A Stratified Approach for Managing Patients With Low Back Pain in Primary Care (SPLIT Program): A Before-and-After StudyLuís Antunes Gomes, Rita Fernandes, Carmen Caeiro, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|July 19, 2018
Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-E and HLA-FMargarida Rodrigues Santos, Ana Rita Couto, Iris Foroni, et al.
Arthritis Research & Therapy|August 23, 2020
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Santiago Rodrigues Manica, Alexandre Sepriano, Fernando Pimentel-Santos, et al.
RMD Open|March 8, 2020
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAIJose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, et al.
Medicine|December 22, 2016
Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohortMargarita Landi, Hernán Maldonado-Ficco, Rodolfo Perez-Alamino, et al.
Acta Reumatologica Portuguesa|August 10, 2018
The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapyElsa Vieira-Sousa, Helena Canhão, Pedro Alves, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Seminars in Arthritis and Rheumatism|July 25, 2025
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?Mariana Emília Santos, Sofia Ramiro, Désirée van der Heijde, et al.
Biomed Research International|April 3, 2015
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapyHelena Canhão, Ana Maria Rodrigues, Maria José Santos, et al.
Pageof 4